Pharmalosophy R&D

The first key step is to make sure you have an initial meeting with the entire team. Have a group discussion regarding the nature of the remit and other key objectives. This way people know how to work together within the context of the project. Having one meeting enables everyone to hear the same message simultaneously...creating clarity that eliminates confusion in the beginning. Listen to this podcast. I will share 4 essential pointers to creating a cohesive team. These key components to discuss during your first team meeting will assist you in getting stuff done quickly as you move forward in the project. You will have more success and a better chance of success if you spend the proper time in the beginning, guaranteed!

The origin of the 'Victim Mentality' topic discussed in this podcast is triggered by the amount and extent of change that takes place within most organizations...and R&D organizations are no exception. Constant change is ever present. Whether it involves either subtle changes in strategy or the extensive change of a mergers or acquisition which happen in the middle of a project, often the project "remit" definition changes sustantially prompting both the project leader (and the team) to feel like they've been derailed or knocked off track (through no fault of their own)...often triggering a "victim mentality" that prompts subsequent efforts to suffer. Learning the subtle differences between responsibility and accountability is the keystone for any learning oganization to be successful. Listen to this podcast. We will discuss key traits to identify victim menatily, how to spend less time in victim mode, learn a process that focuses on improved accountability...and help you enhance and accelerate the results you seek.

The science of managing pharmaceutical stakeholders is very similar to the process of herding cats. Coordinating the energies of a matrix team is typically very challenging. Among many others, the key steps incorporate data review, identifying alternatives, making decisions and offering recommendations to key stakeholders. To move product components through an accelerated drug pipeline is certainly not an easy task...especially with so many minds (and egos) involved! listen to this podcast. We will share four key steps to identifying and working with your key stakeholders. Learn a process that focuses on improved communication...and helps you enhance and accelerate the results you seek.